PubRank

Jose M Mato

Author PubWeight™ 22.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res 2008 2.41
2 MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest 2012 1.86
3 GARBAN: genomic analysis and rapid biological annotation of cDNA microarray and proteomic data. Bioinformatics 2003 1.43
4 Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology 2008 1.27
5 Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl 2010 1.21
6 Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5'-methylthioadenosine. Am J Physiol Gastrointest Liver Physiol 2004 1.14
7 Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology 2007 1.08
8 Binding of S-methyl-5'-thioadenosine and S-adenosyl-L-methionine to protein MJ0100 triggers an open-to-closed conformational change in its CBS motif pair. J Mol Biol 2009 1.07
9 MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer. Hepatology 2013 1.06
10 SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology 2014 0.96
11 S-adenosylmethionine and proliferation: new pathways, new targets. Biochem Soc Trans 2008 0.92
12 Overview of extracellular microvesicles in drug metabolism. Expert Opin Drug Metab Toxicol 2010 0.91
13 A metabolic signature predicts biological age in mice. Aging Cell 2012 0.90
14 Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase. Hepatology 2012 0.88
15 Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity. Metabolomics 2011 0.86
16 Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension. Am J Gastroenterol 2013 0.84
17 Crystallization and preliminary crystallographic analysis of merohedrally twinned crystals of MJ0729, a CBS-domain protein from Methanococcus jannaschii. Acta Crystallogr Sect F Struct Biol Cryst Commun 2008 0.83
18 Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist. Eur Cytokine Netw 2005 0.83
19 Purification, crystallization and preliminary X-ray diffraction analysis of the CBS-domain pair from the Methanococcus jannaschii protein MJ0100. Acta Crystallogr Sect F Struct Biol Cryst Commun 2008 0.79
20 Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease. Hepatology 2012 0.78
21 Proteomics analysis of human nonalcoholic fatty liver. Methods Mol Biol 2012 0.77
22 Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples. Anal Bioanal Chem 2013 0.75